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Abstract
Background: Black flies (Diptera: Simuliidae) feed on blood, and are important vectors of Onchocerca volvulus, the etiolytic
agent of River Blindness. Blood feeding depends on pharmacological properties of saliva, including anticoagulation, but the
molecules responsible for this activity have not been well characterized.
Methodology/Principal Findings: Two Kunitz family proteins, SV-66 and SV-170, were identified in the sialome of the black
fly Simulium vittatum. As Kunitz proteins are inhibitors of serine proteases, we hypothesized that SV-66 and/or 2170 were
involved in the anticoagulant activity of black fly saliva. Our results indicated that recombinant (r) SV-66 but not rSV-170
inhibited plasma coagulation. Mutational analysis suggested that SV-66 is a canonical BPTI-like inhibitor. Functional assays
indicated that rSV66 reduced the activity of ten serine proteases, including several involved in mammalian coagulation. rSV-
66 most strongly inhibited the activity of Factor Xa, elastase, and cathepsin G, exhibited lesser inhibitory activity against
Factor IXa, Factor XIa, and plasmin, and exhibited no activity against Factor XIIa and thrombin. Surface plasmon resonance
studies indicated that rSV-66 bound with highest affinity to elastase (KD=0.4 nM) and to the active site of FXa
(KD=3.07 nM). We propose the name ‘‘Simukunin’’ for this novel protein.
Conclusions: We conclude that Simukunin preferentially inhibits Factor Xa. The inhibition of elastase and cathepsin G
further suggests this protein may modulate inflammation, which could potentially affect pathogen transmission.
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Introduction
Both eukaryotes and prokaryotes produce Kunitz family
protease inhibitors, which indicates an ancient origin for Kunitz
family encoding genes [1,2]. The most conserved function of
Kunitz family proteins is the reversible competitive inhibition of
serine proteases [1]. A single Kunitz domain is small (,60 aa) and
forms a compact globular fold typically containing three disulfide
bonds. Based on the structure of bovine pancreatic trypsin
inhibitor (BPTI), a typical Kunitz domain contains cysteine
residues at positions 5, 14, 30, 38, 51 and 55 in the mature
peptide, which form three disulfide bonds C5–C55, C14–C38 and
C30–C51 [1]. The Kunitz domain may exist singly, or as multiple
domains within a single polypeptide [3]. Many Kunitz domains
act as protease inhibitors through their scissile bond at positions 15
(P1) and 16 (P19). The P1 residue is often a basic amino acid (K or
R) while the P19 position is an A or G, which together interact with
the active site of one or more proteases [1]. Alternative modes of
action have also been characterized. For example, snake venoms
contain Kunitz family proteins named dendrotoxins that exhibit
weak anti-protease activity but strongly block neuronal K
+
channels [4].
Blood coagulation in mammals is a physiological response that
is activated by a complex enzymatic cascade, consisting primarily
of serine proteases, and which terminates with formation of a
fibrin clot. Negative regulators of coagulation are primarily
protease inhibitors, which include one Kunitz family protein
named tissue factor pathway inhibitor (TFPI) [5] that inhibits
formation of FXa by binding to the FVIIa-Tissue factor-FXa
complex [3,5]. Blood-feeding arthropods also produce anti-
hemostatic factors in their saliva, which facilitate blood feeding
by interfering with host hemostatic responses [6]. A variety of anti-
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several Kunitz family proteins in the saliva of ticks [3,7]. For
example, ixolaris from the deer tick, Ixodes scapularis, contains two
kunitz domains. The N-terminal Kunitz displays a glutamic acid
residue in the P1 position, while the C-terminal Kunitz atypically
has only 4 cysteines [8]. Ixolaris binds to the heparin-binding
exosite of coagulation Factor X (FX) and FXa through the C-
terminal domain, and this complex forms a tight-binding inhibitor
of the FVIIa/Tissue Factor complex. The saliva of I. scapularis also
contains penthalaris, which has five Kunitz domains and inhibits
the tissue factor pathway in a manner similar to ixolaris [9]. Other
Kunitz family proteins from tick saliva exhibit functions that range
from anti-thrombin and anti-FXa activity to anti-kallikrein and
anti-platelet aggregation [3,10].
Black flies (Diptera: Simuliidae) like Simulium vittatum are small,
stout-bodied insects. Females of S. vittatum and most other species
must feed on blood from a vertebrate host to produce multiple
clutches of eggs. Black flies are not only a nuisance for humans and
livestock but vector several pathogens including Onchocerca volvulus
that causes onchocerciasis, (river blindness) in humans, and
vesicular stomatitis virus that causes disease in livestock. The bites
of S. vittatum induce a pronounced and persistent erythema [11]
due to the presence of a salivary protein named S. vittatum
erythema protein (SVEP) [12]. S. vittatum saliva also contains at
least three anti-coagulation factors, which exhibit activity against
thrombin, FXa, or FV [13–16]. The identity of these anti-
hemostatic factors, however, remains unknown.
A recent publication on the combined transcriptome and
proteome (collectively called the ‘‘sialome’’) of S. vittatum salivary
glands detected many transcripts and corresponding tryptic
peptide fragments including two Kunitz family proteins, named
SV-66 and SV-170, that could function as anti-coagulation factors
[17]. In this study, we expressed SV-66 and SV-170 and assessed
their anti-coagulant activity. Our results indicated that SV-66 is an
anti-coagulant with anti-FXa activity that also inhibits several
other serine proteases.
Results
2.1. SV-66 and SV-170 encode conserved Kunitz proteins
SV-66 and SV-170 consist of 309 and 237 nucleotides
respectively that encode predicted proteins of 102 and 78 amino
acids (Figure 1A). SignalP identified signal sequences for SV-66
and SV-170 of 19 and 22 amino acids respectively. We assigned
residue numbers based on the predicted mature proteins and
indicated signal sequence residues as negative numbers (Figure 1A).
Alignment with selected other Kunitz-domain containing proteins
indicated that SV-66 and SV-170 possess six conserved cysteine
residues and other conserved residues characteristic of Kunitz
family members (Figure 1B). SV-66 exhibited a basic arginine
residue at position 15, which was the predicted P1 residue. This
finding suggested that SV-66 may be an active protease inhibitor.
In contrast, SV-170 had a threonine at the predicted P1 position,
which suggested a lack of a canonical inhibitory activity against
trypsin-like serine proteases, but which was similar to the C-
terminal Kunitz domain of boophilin [18].
2.2. SV-66 is expressed in female salivary glands
We performed RT-PCR assays to qualitatively assess SV-66
expression in adult S. vittatum. We detected amplicons of expected
size in cDNA samples prepared from the female body (head and
thorax) but did not detect any amplicons from female carcasses
(female body minus salivary glands and head) or adult males
(Fig. 2A). Time course studies indicated that SV-66 was expressed
by adult females prior to blood feeding as well as at all time points
we sampled after blood feeding (Fig. 2B). Taken together, these
results suggested that SV-66 was constitutively expressed in the
salivary glands of adult females but was not expressed in males.
2.3. rSV-66 inhibits plasma clotting, while rSV-170 does
not
We cloned SV-66 and SV-170 cDNAs into the pET-30 Ek/LIC
vector (Novagen) and expressed each in Escherichia coli as
recombinant (r) proteins with C-terminal double His tags. Two-
step purification using Ni
2+ resin and RP-HPLC yielded fractions
highly enriched for rSV-66 or rSV-170 (Figure S1).
We examined the effect of rSV-66 and rSV-170 on the time
needed for fibrin deposition from Ca
2+-stimulated normal human
plasma (clotting time) by measuring the increase in OD at 650 nm.
rSV-66 prolonged coagulation time in a dose-dependent manner,
beginning at concentrations as low as 12.5 nM, whereas rSV-170
exhibited no anti-coagulation activity up to a concentration of
400 nM (Figure 3). Since rSV-170 did not inhibit coagulation, we
focused the remainder of the study on rSV-66. Given its
anticoagulant activity, we named rSV-66 ‘‘Simukunin’’, after a
contraction of Simulium kunitz inhibitor. We also used the name
Simukunin and rSimukunin for recombinant Simukunin during
the remainder of this study.
2.4. Residues in the reactive site loop are important for
rSimukunin anti-coagulation activity
Since canonical Kunitz inhibitors interact with target proteases
through their reactive site loop (RSL), we asked whether alanine
replacement of residues in or adjacent to the RSL affected
Simukunin activity by producing three alanine replacement
mutants, SV66
V13A, SV66
C14A, and SV66
R15A. We also produced
a fourth mutant, SV66
K19A, as a control protein with an alteration
outside of the RSL domain that we hypothesized should not affect
anticoagulation activity. Following purification by Ni
2+ affinity
resin and reversed-phase HPLC, we observed that each recom-
binant protein ran as a doublet on SDS-PAGE gels (not shown).
Tryptic digestion and mass spectrometry analysis, however,
indicated that both bands consisted solely of Simukunin that were
identical to full length native Simukunin. This analysis also
indicated that the low molecular-weight band corresponded to loss
of one of the epitope tags, possibly due to cleavage by an E. coli
protease during the lysis step. We thus concluded the presence of
this lower band should not affect the RSL or activity. However, its
presence necessitated the use of mg rather than molar concentra-
tions in coagulation assays since precise calculation of molar
concentrations was impossible. We therefore conducted anticoag-
ulation assays by adding 0.5 or 1.0 mg of WT or mutant
rSimukunin to plasma and compared the rapidity of clotting to
plasma without rSimukunin by pairwise t-test. The presence of
WT rSimukunin significantly increased clotting time as did
addition of SV66
K19A. In contrast, the addition of SV66
C14A
and SV66
R15A to plasma had no significant effect on clotting
activity. SV66
V13A delayed coagulation, but this effect was
reduced compared to the delay produced by WT rSimukunin
(Figure 4).
2.5. rSimukunin inhibits activity of multiple proteases
including coagulation factors
Preliminary assays indicated that rSimukunin also inhibited the
enzymatic activity of enterokinase, which suggested rSimukunin
could inhibit other serine proteases besides those with roles in host
coagulation. We therefore characterized the inhibitory activity of
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coagulation factors FXa, FXIa, FXIIa, and thrombin. Our results
indicated that rSimukunin significantly reduced the activity of ten
of these proteases (Figure 5). In the coagulation cascade,
rSimukunin significantly inhibited FXa and FXIa, but not
thrombin or FXIIa. Other enzymes strongly inhibited by
Figure 1. SV-66 and SV-170 belong to the Kunitz family of protease inhibitors. (A) Nucleotide and translated polypeptide sequences of SV-
66 and SV-170. Start and stop codons are in white with black shading. Numbers below the amino acid residues are designated based on the putative
mature protein. Signal sequences predicted by SignalP are underlined. Top: SV-66 encodes a 102 amino-acid polypeptide (Simukunin), which includes
a 19 amino-acid N-terminal signal sequence. Mature Simukunin is predicted to consist of 83 amino-acid residues, with a theoretical mass of
9627.22 Da and pI of 9.93. SV-66 also contains a putative O-glycosylation site at position 81 (Ser). Bottom: SV-170 encodes a 78 amino-acid
polypeptide, which includes an N-terminal 22 amino-acid signal sequence. Mature SV-170 is predicted to consist of 56 amino-acid residues, and
theoretical mass and pI are 6526.66 Da and 8.87, respectively. (B) Alignment of representative Kunitz domain sequences with SV-66 and SV-170. Each
Kunitz domain was separated from the original sequences for alignment (numbers denote amino-acid positions in the original mature peptides). All
reference sequences were retrieved from GenBank. Accession numbers are: TFPI (human: 3 Kunitz domains), P10646; BPTI (Bos taurus: 1 Kunitz
domain), AAI49369; Amblin (Amblyomma hebraeum: 2 Kunitz domains), AAR97367; Boophilin (Rhipicephalus microplus: 2 Kunitz domains), CAC82583.
Strictly conserved cysteine residues are white with green shading, and predicted conserved disulfide bonds are shown in solid lines. The reactive site
loop (RSL) P4-P29 residues, conserved in canonical binding inhibitors, are indicated by asterisks. The P1 residue is indicated with an arrow. Highly
conserved P1-P19 (Arg/Lys-Ala/Gly) residues are shown in white with purple shading. Other identical residues across the domain are shaded with
yellow and conserved or semi-conserved residues are shaded with grey.
doi:10.1371/journal.pone.0029964.g001
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and cathepsin G (Figure 5).
We determined the IC50 of rSimukunin to the most strongly
inhibited proteases in order to assess the relative affinity of this
inhibitor for each target (Table 1). To obtain linear reaction rates
within the time frame of the experiment, we assayed each target
enzyme at different molar concentrations. We therefore also
calculated the molar ratio of rSimukunin to the enzyme at the IC50
(Table 1). Collectively, our results indicated that rSimukunin most
strongly inhibited elastase with an IC50 of 4.9 nM and a ratio of
inhibitor to enzyme of 27.22. Factor Xa was also strongly
inhibited, with an IC50 of 5.2 nM and a molar ratio of 52.00, as
Figure 2. SV-66 is constitutively expressed in the salivary glands of adult female S. vittatum. (A) Sex and tissue-specific expression of
Simukunin. Transcript was detected in the adult female body (head and thorax without abdomen), but not in adult female carcasses (bodies without
salivary glands or heads). M: male; F: mature female; NTC: no-template control. 5 individuals were pooled for each sample. Actin PCR products are
shown as a positive control indicating equivalent concentrations of template among samples. Each panel is a composite of two rows (upper and
lower) of wells, run in the same gel at the same time. (B) Time-course of expression of Simukunin. Transcript was detected before, and at selected
time points up to 48 h post blood meal. Fresh: freshly eclosed non-blood-fed female adult; hpbf: hours post blood feeding; NTC: no-template control.
Two samples, each comprised of 5 pooled individuals, were analyzed for each time point.
doi:10.1371/journal.pone.0029964.g002
Figure 3. rSV-66 delays clotting of human plasma. Indicated concentrations of rSimukunin (rSV-66) and rSV-170 were tested by the
recalcification time assay. Citrated human plasma (50 ml) was mixed with recombinant proteins (in 50 ml 0.15 M NaCl, 10 mM HEPES pH7.4) and pre-
warmed at 37uC for 15 min before clotting was initiated by the addition of 50 ml prewarmed CaCl2 (25 mM). Recalcification (clotting) time was
determined by monitoring absorbance at 650 nm at 10-sec intervals in a SpectraMax 340 microtiter plate reader, with onset time (the time to a linear
increase in the OD, which reflects the maximal rate of formation of insoluble fibrin) set at an OD of 0.04. Clotting times (mean 6 SD) for rSimukunin
and rSV-170 are shown in black bars and grey bars, respectively. The white bar is the Ca
2+-only control. One-way analysis of variance indicted a
significant difference between treatments (F6, 21=119.3; P,0.001) for rSimukunin but not rSV-170. Subsequent multiple comparisons between
various treatments and the positive control were performed using the Holm-Sidak method. Statistically significant increases in clotting time at
p,0.05 and p,0.01 are indicated by * and ** respectively. Results shown are representative of three independent experiments.
doi:10.1371/journal.pone.0029964.g003
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tested, including FXIa, required molar excesses of hundreds- to
thousands-fold for 50% inhibition of proteolytic activity.
As elastase, FXa, and cathepsin G were the most strongly
inhibited, based on the ratio of inhibitor to enzyme (Table 1), we
determined the Km for these three enzymes, and then used the
approach of Cheng and Prusoff [19] to calculate the Ki from the
IC50, with a final substrate concentration of 250 uM. The Km for
the elastase substrate was 38.563.3 mM, and the estimated Ki
was,0.65 nM. For FXa the substrate Km was 161.6617.4 mM,
and the estimated Ki was,2.1 nM. For Cathepsin G the Km was
188620 mM, and the Ki was 100 nM. We used a general
Figure 4. Point mutations in the reactive site loop of rSimulkunin disable anti-coagulation activity. Each recombinant protein was
tested by adding 0.5 mg (grey bars) or 1 mg (black bars) to a fixed volume of plasma. Plasma was then pre-warmed at 37uC for 15 min before addition
of 25 mM (8.3 mM final concentration) CaCl2 (pre-warmed) to initiate clotting. White bar shows the Ca
2+-only plasma control. The graph shows mean
6 SD from three independently conducted experiments. p-values for significant differences by one-tailed t-test are shown, where the alternative
hypothesis is that sample recalcification time is greater than the Ca
2+-only control. Statistically significant increases in clotting time at p,0.05 and
p,0.01 are indicated by * and ** respectively.
doi:10.1371/journal.pone.0029964.g004
Figure 5. rSimukunin inhibits several serine proteases. Enzyme activity in the presence of 500 nM of rSimukunin, as a percentage of the total
activity in the absence of inhibitor, is shown. Results with statistically significant (t-test, p,0.01) inhibition compared to the control are shown in
white bars. The graph shows mean 6 SEM. u-PA: urokinase-type plasminogen activator, t-PA: tissue plasminogen activator. Each inhibition assay was
conducted in triplicate.
doi:10.1371/journal.pone.0029964.g005
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substrate is not optimized for Cathepsin G it is likely that our
measurement of the Ki underestimates the effect of rSimukunin.
Further studies of the effect of rSimukunin on Cathepsin G are
planned.
2.6. rSimukunin displays high affinity binding to FXa and
elastase
The preceding results provided measures of affinity for elastase,
FXa, and cathepsin G by rSimukinun, but were insufficient for
calculation of binding and dissociation kinetics. We therefore
conducted Surface Plasmon Resonance (SPR) studies using
rSimukunin immobilized on a sensor chip and used selected
target enzymes as the analyte. These studies showed that
rSimukunin bound FXa from several mammals (human, mouse
and bovine) with high affinity (Figure 6A). rSimukunin also bound
DES-Gla-FXa, an FXa derivative lacking the Gla domain
necessary for docking onto a negatively charged membrane
surface. In contrast, rSimukunin did not bind DEGR-FXa, a
derivative blocked at the active site, or FX, which is the zymogen
precursor of FXa (Figure 6A). rSimukunin also exhibited very
weak binding responses to FIXa and FXIa, and no binding
responses to FVIIa, FXIIIa or thrombin (Figure 6A). Kinetic
analysis determined that FXa bound rSimukunin with a KD of
3.07 nM (Figure 6B and Table 2), but assays with elastase revealed
an even stronger affinity for rSimukunin with a KD=,0.4 nM
(Figure 6C and Table 2). These KD values are consistent with the
Ki values we calculated based on the Km and IC50. The low KD
values for both FXa and elastase result from a fast association rate
(ka1=4.3610
7 M
21 s
21 for elastase) and a very slow off rate
(kd1=0.017 s
21) indicative of rSimukunin functioning as a tight-
binding inhibitor.
Discussion
Salivary gland extracts from S. vittatum have long been known to
have potent anticoagulant activity, but the identity of the
molecules involved had heretofore remained uncharacterized. In
the current study, we show that of the two Kunitz family proteins
expressed in the salivary glands of female S. vittatum [17], rSV-66,
which we name Simukunin, dose-dependently prolongs coagula-
Table 1. IC50 values for rSimukunin against various serine
proteases.
Enzyme Concentration (nM) IC50 (mean ± SEM (nM) Ratio
Elastase 0.18 4.960.6 27.22
Cathepsin G 6.7 217.465.7 32.45
Factor Xa 0.1 5.260.3 52.00
Plasmin 0.2 32.265.2 161.00
Factor XIa 0.06 56.7613.1 945.00
Kallikrein 0.08 91.866.3 1147.50
Trypsin 0.1 379.3630.2 3793.00
b-Tryptase 0.01 66.8614.6 6680.00
Titrated concentrations of rSimukunin were tested with constant
concentrations of enzymes (in Concentration column) to determine the
concentrations of rSimukunin that gave a 50% inhibition of the enzyme activity.
Ratios of IC50 to enzyme concentration are also shown as different
concentrations of enzymes were necessary to obtain linear reaction rates.
Titration curves are shown in Figure S2.
doi:10.1371/journal.pone.0029964.t001
Figure 6. rSimukunin displays high-affinity binding to FXa and
elastase. (A) Surface Plasmon Resonance (SPR) Sensorgrams show
mouse, bovine, and human FXa, the FXa derivatives des-GLA-hFXa and
DEGR-hFXa, and other coagulation factors (all tested at 200 nM)
binding to immobilized rSimukunin. (B) Sensorgrams for various
concentrations of human FXa (in nM: purple, 50; red, 25; orange, 12.5;
green, 6.25, blue, 3.1) binding to immobilized rSumukunin. (C)
Sensorgrams for various concentrations of elastase (in nM: red, 3.75;
orange, 1.8; green, 0.9; blue, 0.45) binding to immobilized rSimukunin.
Data were fitted using a 1:1 binding model (Langmuir). RU: resonance
units.
doi:10.1371/journal.pone.0029964.g006
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activity. Simukunin is constitutively expressed specifically in adult
female salivary glands, which is consistent with a role in blood
feeding.
Our SPR results strongly suggest that the anticoagulant activity
of Simukunin is primarily due to high affinity binding to FXa. In
contrast, rSimukinin does not bind to the zymogenic form of FX,
which suggests this inhibitor only interacts with the activated
enzyme. Our results further show that rSimukunin exhibits
binding to des-Gla-FXa but does not interact with DEGR-FXa,
which is blocked specifically at the active site. These data together
with outcomes of our mutagenesis studies strongly suggest that
rSimukunin interacts directly with the active site of FXa. That
FXa is a primary target of rSimukunin is also supported by our
results showing that rSimukunin does not interact with FVIIa,
FXIIa, FXIIIa, or thrombin, and only weakly interacts with FIXa
and FXIa.
The loss of anticoagulation activity by SV66
R15A is fully
consistent with the hypothesis that rSimukunin interacts directly
with the active site of FXa, and that Arg15 functions as the P1
residue. The reduced activity of SV66
V13A could likewise reflect a
less stable interaction with the catalytic active site of FXa, while
the lack of activity of SV66
C14A likely reflects an alteration in
structure due to elimination of the Cys14–Cys38 disulfide bond.
Taken together, we think it likely that Simukunin acts similarly to
BPTI, whose basic P1 residue, Lys15, is critical for the inhibition of
trypsin and chymotrypsin [20] through stable docking into the S1
specificity subsite of these enzymes and formation of polar
interactions with a negatively charged Asp189 side chain [1].
The anti-clotting activity of Simukunin may account for the
anti-FXa activity of black fly SGE described previously [13].
However, the estimated size of a partially characterized FXa
inhibitor was 18000 Da [13], which is much larger than the
predicted size of Simukunin (9627.22 Da). Although Simukunin
has a putative O-glycosylation site in the C-terminal region, the
1D SDS-PAGE gel band from which Simukunin tryptic fragments
were recovered migrated between the 14.1 and 6 kDa markers in
Andersen et al. [17], which indicates that glycosylation does not
significantly add to the native size of Simukunin. The relationship
between Simukunin and the previously described anti-FXa activity
thus remains unclear but it is possible that other proteins
contribute to the anti-FXa activity in black fly saliva.
Although rSimukunin inhibited kallikrien in our screening
assay, the activity was modest, and further, it did not inhibit
bradykinin production from kaolin-activated human plasma (JMC
Ribeiro, pers. Commun. May 21, 2010), indicating that the FXII/
prekallidrein/kallikrein pathway is not a target of this inhibitor.
Coagulation and inflammation are linked through a variety of
cross-talk mechanisms [21]. For example, proteinase-activated
receptor 4, which is highly expressed on platelets, is activated
following cleavage by FXa or thrombin and subsequently mediates
inflammatory responses [21,22]. As Simukunin inhibits FXa,
which indirectly reduces subsequent thrombin activation, it is
likely that Simukunin may also influence inflammatory responses
at the bite site, though we have not yet examined this
experimentally.
Our comparative data clearly show that rSimukunin binds to
and/or inhibits several other enzymes besides FXa including
major components of neutrophil azurophil granules such as
elastase, and mast cell proteases including cathepsin G, tryptase,
and chymase. Indeed, the strongest binding affinity we detected
was between rSimukunin and elastase. This finding together with
inhibition of cathepsin G is notable because both enzymes function
in killing phagocytized microbes by neutrophils. Extracellular
release of cathepsin G mediates platelet aggregation, which is
known to provide a surface for assembly of the prothrombinase
complex [21]. Thus, inhibition of cathepsin G could indirectly
antagonize coagulation. Cathepsin G, tryptase, and elastase also
regulate the function of several chemokines, cytokines, cell surface
receptors and adhesion molecules [23–26], which leads to the
possibility that Simukunin may affect inflammation or other
responses in proximity to sites of black fly feeding. Further
experimental work will be necessary to examine the effect of
Simukunin on macrophage, mast cell, and neutrophil function.
The inhibition of elastase by rSimukunin is somewhat surprising
in light of prior studies showing that Kunitz domain inhibitors of
elastase like Bikunin (formerly called acid stable trypsin inhibitor
or ASTI, or urinary trypsin inhibitor) have an aliphatic amino
acid, such as methionine, leucine, or valine in the P1 position [27–
30]. We thus speculate that residues outside the RSL either orient
the Simukunin/elastase interaction to permit tight binding despite
the unfavorable P1 residue, or that binding and inhibition involves
interactions with a domain distinct from the RSL. Future
structure-function experiments, however, will be required to
understand how Simukunin interacts with this enzymatic target.
Inhibition of multiple enzymes by rSimukunin, is also not
unusual for Kunitz family inhibitors from blood-feeding arthro-
pods and other organisms. For example, the archetypical Kunitz
protein BPTI inhibits trypsin with a Ki of 0.06 pM, but it also
inhibits chymotrypsin (Ki=9 nM), plasmin, and kallikrein [31].
Boophilin, a tick salivary protein with two Kunitz domains,
likewise exhibits significant inhibitory activity toward thrombin,
trypsin, plasmin, and plasma kallikrein [18], while the serpin IRS-
2 has inhibitory activity against cathepsin G, chymase, and a-
chymotrypsin [32]. On the other hand, Kunitz family thrombin
inhibitors from soft ticks appear to specifically inhibit thrombin at
pM concentrations (eg. ornithodorin, Ki=1 pM [33]; savignin,
Ki=4.89 pM) [34]. Lastly, we note that the binding affinities of
Simukunin for FXa (KD=3.071 nM) and elastase (KD=0.4 nM)
are broadly consistent with the binding affinities determined for
other Kunitz inhibitors from blood feeding species. As examples,
the tick salivary inhibitor ixolaris binds to FX and FXa with KDso f
0.67 and 0.25 nM respectively [35], while boophilin binds
thrombin with a Ki of 1.8 nM [18], as does amblin, with a Ki of
20 nM [36].
Future functional studies will be needed to fully characterize the
role of Simulkunin in blood feeding. Nonetheless, our results
collectively suggest Simukunin facilitates blood-feeding by disrupt-
ing coagulation and possibly by interfering with host inflammatory
responses. Several examples from mosquitoes and sandflies also
implicate saliva in potentiating pathogen transmission by modu-
lating immune responses in the host skin (reviewed in [37–39]).
However, future studies will be required to determine whether
Table 2. Kinetics of FXa and Elastase interactions with
rSimukunin.
Enzyme ka1(M
21 s
21) kd1(s
21) KD (nM)
FXa 9.87610
4 3.032610
24 3.071
Elastase 4.302610
7 0.01727 0.40
Responses were obtained by injecting FXa or elastase over immobilized
rSimukunin for 180 seconds at a flow rate of 30 ml/minute. Data were derived
from Ka1 and Kd1 and fitted using the Langmuir (1:1 binding) equation. Kinetic
values obtained from the sensorgrams presented in Figure 6B and 6C for FXa
and elastase respectively.
doi:10.1371/journal.pone.0029964.t002
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note that recent studies of the sialome from another black fly,
Simulium nigrimanum, identified four Kunitz protein-encoding
transcripts, which are divided into two subfamilies based on the
presence or absence of a C-terminal extension of basic residues
[40]. Therefore, S. nigrimanum salivary glands may also produce
multiple Kunitz anti-coagulation factors with potential roles in
regulating coagulation and inflammation.
Materials and Methods
4.1. S. vittatum culture
S. vittatum was reared at the Department of Entomology, the
University of Georgia, according to previously described condi-
tions [41,42]. Because S. vittatum is facultatively autogenous, no
vertebrate animals were used in the study for rearing or
maintenance of insects.
4.2. Salivary gland dissection, cDNA synthesis, and
expression analyses
Adult female flies (collected 2–3 days post eclosion) were chilled
on ice, and their salivary glands were collected by dissection under
a stereomicroscope in sterile HEPES saline (HS) (10 mM HEPES
pH 7.0, 150 mM NaCl). Fifty salivary gland pairs were collected
in 20 mL HS, mixed with 20 mL RNAlater (Ambion, Foster City,
CA), and stored at –70uC until use. Total RNA was isolated using
Trizol reagent (Invitrogen, Carlsbad, CA). Genomic DNA was
removed using RNase-free DNase (Turbo DNase, Ambion, Foster
City, CA). First strand cDNA was synthesized using 100 ng of total
RNA, SuperScript III (Invitrogen, Carlsbad, CA) and an oligo
d(T) primer (59-(T)25-VN-39)a t5 0 uC for 60 min, followed by
enzyme inactivation at 70uC for 15 min. Resultant cDNA was
then stored at 220uC until use.
Total RNA was isolated and reverse transcribed as described
above from female flies without salivary glands and head (termed
‘‘carcass’’), intact female flies, and intact males flies. Since S.
vittatum is autogenous for the first gonotrophic cycle, we also
reverse transcribed RNA from female bodies without abdomens
(in order to avoid collecting vertebrate cells in the blood meal)
collected after the first oviposition, and at 3, 6, 12, 24, and 48 hrs
post blood-feeding (pbf). Blood-fed flies were kept at 27uC with
constant access to sugar water (10% sucrose). RT-PCRs were then
run using an Eppendorf thermocycler in 25 ml reaction volumes
containing 1 ml of cDNA and 2.5 mM of SV-66 UA and SV-66
DA primers (Table S1). Cycling conditions were as follows: initial
2 min denaturation at 94uC, followed by 30 cycles at 30 sec at
94uC, 30 sec at 57uC 30 sec at 72uC, and a final 5 min extension
at 72uC. Actin from S. vittatum (GenBank accession number
AY083375.1) amplified using SVactinUA and SVactinDA primers
(Table S1) was used as an endogenous control.
4.3. Cloning and sequence analysis of Kunitz family
proteins
Full-length cDNAs for SV-66 and SV-170 (GenBank accession
numbers EU930300 and EU930227, respectively) [17] were
amplified from salivary gland cDNA using Platinum HIFI Taq
DNA polymerase and gene specific primers (SV66 UA, SV66DA,
SV170UA, SV170DA) in 25 ml reactions. PCR conditions were:
initial 2 min denaturation at 94uC, followed by 35 cycles (30 sec at
94uC, 30 sec at 57uC 30 sec at 68uC), and a final 5 min extension
at 68uC. The resulting amplicons were then TA cloned into
pCR4-TOPO (Invitrogen), and transformed into E. coli TOP10
competent cells (Invitrogen). After overnight culture, the plasmids
SV66/TOPO and SV170/TOPO were purified using the Wizard
Plus miniprep DNA purification system (Promega, Madison, WI)
and quantified using a NanoDrop spectrophotometer (Thermo
Scientific, Wilmington, DE). Inserts were sequenced (Macrogen,
Rockville, MD) to confirm fidelity with the reference sequences.
SignalP [43] was used to predict signal peptide sequences, and
NetOGlyc [44] was used to predict potential glycosylation sites.
Alignments were performed using Clustal W2 [45] against other
Kunitz domains from the following Kunitz inhibitors: bovine
pancreatic trypsin inhibitor (BPTI) (Genbank accession number
AAI49369) from Bos taurus (a single Kunitz domain inhibitor);
human tissue factor pathway inhibitor (TFPI) (P10646) (consisting
of 3 Kunitz domains); a thrombin inhibitor, amblin, (AAR97367)
from the tick Amblyomma hebraeum (2 Kunitz domains); and a
prothrombinase inhibitor, boophilin, (CAC82583) from the tick
Rhipicephalus (Boophilus) microplus (2 Kunitz domains).
4.4. Protein expression and purification
For bacterial expression of SV-66 and SV-170, full-length ORFs
without signal peptides were PCR amplified using SV66/TOPO
or SV170/TOPO as template, the primers SV66UB/SV66DB or
SV170UB/SV170DB (Table S1), and Elongase polymerase
enzyme mix (Invitrogen). The resulting products were then
directly cloned in frame with the C-terminal His-tag of the vector
pET-30 (Novagen) using T4 polymerase. We generated the
mutants SV66
V13A, SV66
C14A, SV66
R15A, and SV66
K19A using
the Quick Change site-directed mutagenesis kit (Strategene)
together with the primers V13A-UA/V13A-DA, C14A-UA/
C14A-DA, R15A-UA/R15A-DA, and K19A-UA/K19A-DA
respectively. Each of these constructs were confirmed by DNA
sequencing, and then expressed by transforming into E. coli BL21
(DE3) cells cultured in SOC medium (0.5% Yeast Extract, 2%
Tryptone, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2,1 0m M
MgSO4, 20 mM Glucose), supplemented with 10 ug/ml of
kanamycin to an O.D. of 1.0 at 37uC. We then added 0.1 mM
isopropyl-b-d-thiogalactopyranoside (IPTG) to the cultures and
grew an additional 17–24 h at 20uC. Bacterial cells were harvested
by centrifugation at 45006g for 10 min and used immediately or
stored at 280uC.
Bacterial pellets from 0.8 L cultures were resuspended in 40 ml
of lysis buffer (50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM
imidazole). After addition of lysozme (1 mg/ml) in 50 mM Tris-
HCl (pH 8.0), cells were incubated on ice for 1 h followed by two
freeze-thaw cycles and sonication with six, 10 sec bursts at 300 W
using a Branson 450 Sonifier (VWR). The lysate was then
centrifuged at 13,0006g for 10 min, followed by 3 h incubation of
the supernatant with Ni-NTA Superflow beads (Qiagen) pre-
equilibrated with lysis buffer. After washing, attached proteins
were eluted with three column volumes of elution buffer (50 mM
Tris-HCl pH 8.0, 300 mM NaCl, 300 mM imidazole), followed
by desalting and concentration using an Amicon Ultra-4 3000
MWCO spin column (Millipore, USA). Proteins were quantified
using the Micro BCA Protein Assay Kit (Pierce) and visualized
after SDS-polyacrylamide gel electrophoresis (PAGE) (4–20%
precast gels (Lonza)) by staining with Coomassie Blue.
Recombinant proteins were further purified by reversed-phase
high-performance liquid chromatography (RP-HPLC) using a
Jupiter C4 column (5 mm particle size, 300 A ˚ pore size, 250 mm
length62.00 mm ID) (Phenomenex, Torrance, CA) with a linear
gradient between 95% H2O/5% acetonitrile (ACN)/0.05%
trifluoroacetic acid (TFA)) and 95% ACN/5% H2O/0.03%
TFA) monitored at 220 nm. Fractions were collected every
minute, lyophilized to remove ACN and TFA, resuspended in
20 mM Tris pH 8.0, and quantified by the BCA method
described above. Purity of the proteins was assessed by SDS-
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Separated proteins were transferred onto a polyvinylidene fluoride
(PVDF) membrane (Bio Rad, Hercules, CA), blocked in 16PBS
containing 0.05% Tween-20 and 2% non-fat skim milk for 1 hour
at room temperature, and incubated with an anti-His primary
antibody (His-probe (H-15); Santa Cruz Biotechnology) (1:5000).
The membrane was washed three times with 16PBS containing
0.05% Tween-20, incubated with goat anti-rabbit secondary
antibody conjugated to horseradish peroxidase (Jackson Immuno
Research) (1:10000), and visualized by chemiluminescence using
the ECL Plus Western Blotting system (GE Healthcare, Piscat-
away, NJ).
4.5. Recalcification assay
Recalcification assays were performed as described by Valen-
zuela et al [46]. Briefly, 10 mL of various concentrations of
recombinant proteins, 40 mL of 0.15 M NaCl, 10 mM HEPES
pH7.4 and 50 mL of citrated human plasma (TriniCHECK Level
1, Trinity Biotech, Co Wicklow, Ireland) were mixed in a flat-
bottomed 96-well plate and prewarmed at 37uC for 15 min. To
initiate plasma clotting, 50 mL of 25 mM CaCl2 prewarmed to
37uC was added in the 96-well plate. Immediately after the
addition of CaCl2 absorbance was taken at 650 nm at 10-sec
intervals by microtiter plate reader at 37uC (SpectraMax 340,
Molecular Devices, Sunnyvale, CA). Clotting onset time (‘‘Clotting
Time’’) was set at the time when the absorbance reached an
optical density (OD) of 0.04, where the increase in OD is linear.
One-way ANOVA, followed by pairwise comparisons of treatment
values to the CaCl2-only control using the Holm-Sidak method,
was used for the statistical analysis; when p,0.05, the difference
was considered as statistically significant.
4.6. Serine protease inhibition assays
rSimukunin (500 nM) was first pre-incubated with each enzyme
for 10 min before the addition of the corresponding substrate. The
amount of enzyme used in the assays was the lowest possible to
give a linear substrate hydrolysis rate in the assays (r
2.0.95). After
incubation for 5 min at 30uC, substrate hydrolysis rate was
followed in a Tecan Infinite M200 96-well plate fluorescence
reader (Tecan group Ltd, Switzerland) using 365 nm excitation
and 450 nm emission wavelength with a cutoff at 435 nm for
20 min at 30uC. Wells without enzyme were used to monitor
spontaneous substrate hydrolysis and protease contamination in
the inhibitor preparation. A t-test was used for the statistical
analysis of the observed inhibition in the presence of 500 nM
rSimukunin and when p,0.05, it was considered as statistically
significant.
IC50 estimates were determined as previously described [47],
using decreasing concentrations of rSimukunin pre-incubated for
5 min with a given target enzyme, followed by addition of
substrate. All experiments were performed in triplicate (for each
enzyme and each concentration of the inhibitor). The mean
percentage of enzymatic activity in the presence of various
rSimukunin concentrations was then compared with enzymatic
activity in the absence of rSimukunin. The sigmoidal fit of the data
then yielded the estimate for the IC50 of rSimukunin for the
various enzymes. The resulting titration curves are provided in
Figure S2.
All enzymes used were of human origin and of the highest
available purity. The source and concentration of the enzymes
used in the serine protease screen assays follows: Thrombin
(0.02 nM), a-chymotrypsin (0.025 nM), plasmin (0.2 nM) and
chymase (1.8 nM) were purchased from Sigma (St. Louis, MO),
skin b-tryptase (0.01 nM) was purchased from Promega (Madison,
WI), activated coagulation factor X (FXa) (0.1 nM) was purchased
from EMD Biosciences (La Jolla, CA), FXIIa (0.1 nM) was
purchased from Haematologic Technologies Inc. (Essex Junction,
VT), kallikrein (0.08 nM) was purchased from Fitzgerald Indus-
tries International (Concord, MA), elastase (0.18 nM) was
purchased from Elastin Products (Owensville, MO), FXIa
(0,06 nM), urokinase-type plasminogen activator (u-PA) (0.5 nM)
and tissue plasminogen activator (t-PA) (0.06 nM) from Molecular
Innovations (Southfield, MI), matriptase (0.2 nM) from R&D
Systems (Minneapolis, MN), cathepsin G (6.7 nM) from Enzo Life
Sciences (Plymouth Meeting, PA) and sequencing grade trypsin
(0.1 nM) was purchased from Roche (Chicago, IL). The amount of
enzyme used in each of the IC50 estimation assays is shown also in
the Table 1.
Assay buffers were: 1) for elastase and chymase, 50 mM HEPES
buffer pH 7.4, 100 mM NaCl, 0.01% Triton X-100; 2) for trypsin,
a-chymotrypsin, factor XIa, factor XIIa and thrombin, 50 mM
Tris buffer pH 8.0, 150 mM NaCl, 20 mM CaCl2, 0.01% Triton
X-100; 3) for b-tryptase, 50 mM Tris pH 8.0, 50 mM NaCl,
0.05% Triton X-100; 4) for kallikrein, matriptase and plasmin,
20 mM Tris buffer pH 8.5, 150 mM NaCl, 0.02% triton X-100;
5) for factor Xa, 20 mM Tris buffer pH 8.0, 200 mM NaCl,
5 mM CaCl2, 0.1%BSA; 6) for u-PA and t-PA, 20 mM Tris buffer
pH 8.5, 0.05% Triton X-100; 7) for cathepsin G, 50 mM Tris
buffer pH 7.4, 150 mM NaCl, 0.01% Triton X-100. Peptidyl
substrates used were: Suc-A-A-P-V-AMC for elastase, a-chymo-
trypsin and chymase (EMD Biosciences, La Jolla, CA); Boc-D-P-
R-AMC for thrombin and plasmin; Boc-Q-A-R-AMC for trypsin,
factor XIa and u-PA (Sigma, St. Louis, MO); Boc-F-S-R-AMC for
b-tryptase; Suc-L-L-V-Y-AMC for chymase (Bachem, King of
Prussia, PA); and methylsulfonyl-D-cyclohexylalanyl-G-R-AMC
acetate for factor Xa, factor XIIa, t-PA, matriptase and kallikrein
(American Diagnostica Inc., Stamford, CT). All substrates were
used at 250 mM final concentration in all the assays.
4.7. Surface plasmon resonance (SPR) assays
SPR experiments were conducted using a T100 instrument
(Biacore Inc., Uppsala, Sweden) following the manufacturer’s
instructions. Sensor CM5, amine coupling reagents, and buffers
were also purchased from Biacore Inc. (Piscataway, NJ, USA).
HBS P (10 mM Hepes, pH 7.4, 150 mM NaCl, and 0.005% (v/v)
P20 surfactant) was used as the running buffer for all SPR
experiments, which were carried out as previously described [28].
For analytes, FVIIa (recombinant) was purchased from American
Diagnostica (Stamford, CT); FX, FXa (human, bovine, mouse),
DEGR-FXa (human), des-Gla-FXa (human), FIXa, FXIa, FXIIIa,
and thrombin were purchased from Haematologic Technologies,
Inc. (Essex Junction, VT); elastase (purified from human sputum)
was purchased from Molecular Innovations, Inc. (Novi, MI). All
enzymes were of the highest available purity. For immobilization
and kinetic analysis, rSimukunin (10 mg/ml) in acetate buffer
pH 5.0 was immobilized over a CM5 sensor via amine coupling,
resulting in a final immobilization of 475.3 RU. Kinetic
experiments were carried out with a contact time of 180 seconds
at a flow rate of 30 ml/minute at 25uC. rSimukunin-FXa complex
dissociation was monitored for 1800 seconds, and the sensor
surface was regenerated by a pulse of 30 seconds of 20 mM HCl at
30 ml/minute. In other experiments, other coagulation factors or
enzymes were used as analytes. Blank flow cells were used to
subtract the buffer effect on sensorgrams. After subtraction of the
contribution of bulk refractive index and nonspecific interactions
with the CM5 chip surface, the individual association (ka) and
dissociation (kd) rate constants were obtained by global fitting of
data to a 1:1 interaction model (Langmuir) using BIAevaluation
TM
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SP66zFXa
ka1
kd1
SP66 : FXa
Values were then used to calculate the dissociation constant (KD).
Conditions were chosen so that the contribution of mass transport
to the observed values of KD was negligible. Also, models in the
T100 evaluation software fit for mass transfer coefficient to
mathematically extrapolate the true ka and kd.
Supporting Information
Figure S1 Visualization of rSV-66 and rSV-170 following
separation by SDS-PAGE (left panel) and immunoblot-
ting (right panel). The SDS-PAGE gel was stained with
Coomassie Brilliant Blue, while the immunoblot was probed with
an anti-His primary antibody and visualized by chemilumines-
cence. Lanes were loaded with bacterial lysate (L), Ni
2+ resin
purified protein, (Ni
2+), or protein further purified by RP-HPLC
(HPLC). Western blotting of the bacterial lysates was done
separately from the Ni
2+ and RP-HPLC purified proteins. The
figure is therefore a composite, with the lysate lanes aligned with
the others based on protein standards, but blotting protocols were
identical for all samples.
(TIF)
Figure S2 Determination of rSimukunin IC50 values for
selected serine proteinases. Enzymes, at the concentrations
given in Table 1, were incubated with the indicated concentration
of rSimukunin for 5 min at 30uC, followed by addition of substrate
(250 mM final concentration). The amount of enzyme used in the
assays was the lowest possible to give a linear substrate hydrolysis
rate in the assays (r
2.0.95). Substrate hydrolysis was followed in a
Tecan Infinite M200 96-well plate fluorescence reader (Tecan group
Ltd, Switzerland) using 365 nm excitation and 450 nm emission
wavelength with a cutoff at 435 nm for 20 min at 30uC. Wells
without enzyme were used to monitor spontaneous substrate
hydrolysis and protease contamination in the inhibitor prepara-
tion. All experiments were performed in triplicate (for each
enzyme and each concentration of the inhibitor). The mean
percentage of enzymatic activity in the presence of various
rSimukunin concentrations was then compared with enzymatic
activity in the absence of rSimukunin. The sigmoidal fit of the data
then yielded the estimate for the IC50 of rSimukunin for the
various enzymes reported in Table 1.
(TIF)
Table S1 PCR primers used in this study. For primers
used for cloning in pET-30, direction-specific LIC sites are
underlined. For primers used for single His-tag constructs, bold
letters indicate the stop codon (TAA) and the read-through Ala
(GCA in reverse-complement orientation).
(DOC)
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